Selected research
Industry Research
Memantine Industry Research Report 2026
Market perspective
The global Memantine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Memantine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Memantine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Memantine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Memantine include Eisai Co, Johnson & Johnson, Novartis AG, Ono Pharmaceutical Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited and Allergan, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Memantine market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Memantine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Memantine Market by Company
Eisai Co
Johnson & Johnson
Novartis AG
Ono Pharmaceutical Co Ltd
H Lundbeck A/S
Daiichi Sankyo Company Limited
Allergan
Memantine Segment by Type
Memantine Powder
Memantine Capsule
Memantine Tablet
Memantine Segment by Application
Hospital Pharmacy
Retail Pharmacy
Memantine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Memantine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Memantine Powder
- Memantine Capsule
- Memantine Tablet
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- Eisai Co
- Johnson & Johnson
- Novartis AG
- Ono Pharmaceutical Co Ltd
- H Lundbeck A/S
- Daiichi Sankyo Company Limited
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Memantine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Memantine Powder
- 2.2.3 Memantine Capsule
- 2.2.4 Memantine Tablet
- 2.3 Memantine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacy
- 2.3.3 Retail Pharmacy
- 2.4 Assumptions and Limitations
3 Memantine Breakdown Data by Type
- 3.1 Global Memantine Historic Market Size by Type (2021-2026)
- 3.2 Global Memantine Forecasted Market Size by Type (2027-2032)
4 Memantine Breakdown Data by Application
- 4.1 Global Memantine Historic Market Size by Application (2021-2026)
- 4.2 Global Memantine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Memantine Market Perspective (2021-2032)
- 5.2 Global Memantine Growth Trends by Region
- 5.2.1 Global Memantine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Memantine Historic Market Size by Region (2021-2026)
- 5.2.3 Memantine Forecasted Market Size by Region (2027-2032)
- 5.3 Memantine Market Dynamics
- 5.3.1 Memantine Industry Trends
- 5.3.2 Memantine Market Drivers
- 5.3.3 Memantine Market Challenges
- 5.3.4 Memantine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Memantine Players by Revenue
- 6.1.1 Global Top Memantine Players by Revenue (2021-2026)
- 6.1.2 Global Memantine Revenue Market Share by Players (2021-2026)
- 6.2 Global Memantine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Memantine Head Office and Area Served
- 6.4 Global Memantine Players, Product Type & Application
- 6.5 Global Memantine Manufacturers Established Date
- 6.6 Global Memantine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Memantine Market Size (2021-2032)
- 7.2 North America Memantine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Memantine Market Size by Country (2021-2026)
- 7.4 North America Memantine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Memantine Market Size (2021-2032)
- 8.2 Europe Memantine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Memantine Market Size by Country (2021-2026)
- 8.4 Europe Memantine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Memantine Market Size (2021-2032)
- 9.2 Asia-Pacific Memantine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Memantine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Memantine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Memantine Market Size (2021-2032)
- 10.2 South America Memantine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Memantine Market Size by Country (2021-2026)
- 10.4 South America Memantine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Memantine Market Size (2021-2032)
- 11.2 Middle East & Africa Memantine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Memantine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Memantine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eisai Co
- 12.1.1 Eisai Co Company Information
- 12.1.2 Eisai Co Business Overview
- 12.1.3 Eisai Co Revenue in Memantine Business (2021-2026)
- 12.1.4 Eisai Co Memantine Product Portfolio
- 12.1.5 Eisai Co Recent Developments
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Company Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Revenue in Memantine Business (2021-2026)
- 12.2.4 Johnson & Johnson Memantine Product Portfolio
- 12.2.5 Johnson & Johnson Recent Developments
- 12.3 Novartis AG
- 12.3.1 Novartis AG Company Information
- 12.3.2 Novartis AG Business Overview
- 12.3.3 Novartis AG Revenue in Memantine Business (2021-2026)
- 12.3.4 Novartis AG Memantine Product Portfolio
- 12.3.5 Novartis AG Recent Developments
- 12.4 Ono Pharmaceutical Co Ltd
- 12.4.1 Ono Pharmaceutical Co Ltd Company Information
- 12.4.2 Ono Pharmaceutical Co Ltd Business Overview
- 12.4.3 Ono Pharmaceutical Co Ltd Revenue in Memantine Business (2021-2026)
- 12.4.4 Ono Pharmaceutical Co Ltd Memantine Product Portfolio
- 12.4.5 Ono Pharmaceutical Co Ltd Recent Developments
- 12.5 H Lundbeck A/S
- 12.5.1 H Lundbeck A/S Company Information
- 12.5.2 H Lundbeck A/S Business Overview
- 12.5.3 H Lundbeck A/S Revenue in Memantine Business (2021-2026)
- 12.5.4 H Lundbeck A/S Memantine Product Portfolio
- 12.5.5 H Lundbeck A/S Recent Developments
- 12.6 Daiichi Sankyo Company Limited
- 12.6.1 Daiichi Sankyo Company Limited Company Information
- 12.6.2 Daiichi Sankyo Company Limited Business Overview
- 12.6.3 Daiichi Sankyo Company Limited Revenue in Memantine Business (2021-2026)
- 12.6.4 Daiichi Sankyo Company Limited Memantine Product Portfolio
- 12.6.5 Daiichi Sankyo Company Limited Recent Developments
- 12.7 Allergan
- 12.7.1 Allergan Company Information
- 12.7.2 Allergan Business Overview
- 12.7.3 Allergan Revenue in Memantine Business (2021-2026)
- 12.7.4 Allergan Memantine Product Portfolio
- 12.7.5 Allergan Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst